Zeneus Pharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer (NCT00250874) | Zeneus Pharma | 2003-12-01 |
| Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL. (NCT00244127) | Zeneus Pharma | 2002-10-01 |
Track Zeneus Pharma automatically
Every clearance here is in the API, with alerts when new ones post.